-
Carlo SelmiHumanitas Univ.Italy
-
Carlo Selmi received his MD in 1998 and his PhD in Internal Medicine in 2002, both from the University of Milan. Between July 2005 and december 2014, he was Assistant Adjunct Professor of Medicine at the same Division at UC Davis. Since 2022, he is Full Professor of Internal Medicine at the Humanitas University in Milan; he currently leads the Rheumatology and Clinical Immunology Unit at Humanitas research hospital.
Prof. Selmi has coauthored over 350 peer-reviewed publications with a Scopus H index of 65. His research track is dedicated to organ-specific and systemic autoimmune and chronic inflammatory diseases, including the clinical epidemiology and pathogenetic mechanisms of autoimmune liver disease, connective tissue disease (particularly systemic sclerosis), and psoriatic arthritis.
| Date | Time | Room | Session Title | Lecture Title |
|---|---|---|---|---|
| May 20 | 12:00-12:40 | Room C | [Luncheon Symposium VI - Yuhan] The New Adalimumab Option in Rheumatic Diseases Treatment | ADALLOCE®(SB5) adalimumab in rheumatic diseases: Data from clinical trials and the real world |
